Highlight: The 4th international symposium on Kallikreins and Kallikrein-Related Peptidases

Biological Chemistry

Volumn 393, Issue 5, 2012, Pages 299-300

  Scorilas, Andreas ^a   Mavridis, Konstantinos ^a   Magdolen, Viktor ^b   Fritz, Hans ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; KALLIKREIN 6; KALLIKREIN RELATED PEPTIDASE; MATRIX METALLOPROTEINASE; MICRORNA; PEPTIDASE; UNCLASSIFIED DRUG;

AWARDS AND PRIZES; BINDING SITE; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; DNA METHYLATION; EDITORIAL; ENZYME ACTIVATION; ENZYME INHIBITION; INFLAMMATION; KIDNEY DISEASE; NETHERTON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SYMPOSIUM; UNITED STATES;

HUMANS; KALLIKREINS; NEOPLASMS;

EID: 84859808293     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2012-0122     Document Type: Editorial

References (14)

1. Arnold, S., Pampalakis, G., Kantiotou, K., Silva, D., Cortez, C., Missailidis, S., and Sotiropoulou, G. (2012). One round of SELEX for the generation of DNA aptamers directed against KLK6. Biol. Chem. 393, 343-353.
2. Avgeris, M., Mavridis, K., and Scorilas, A. (2012). Kallikreinrelated peptidases in prostate, breast, and ovarian cancers: from pathobio logy to clinical relevance. Biol. Chem. 393, 301-317.
3. Brännström, K., Öhman, A., von Pawel Rammingen, U., Olofsson, A., and Brattsand, M. (2012). Characterization of SPINK9, a KLK5-specific inhibitor expressed in palmo-plantar epidermis. Biol. Chem. 393, 369-377.
4. Chung, H., Hamza, M., Oikonomopoulou, K., Gratio, V., Saifeddine, M., Virca, G.D., Diamandis, E.P., Hollenberg, M.D., and Darmoul, D. (2012). Kallikrein-related peptidase signaling in colon carcinoma cells: targeting proteinase-activated receptors. Biol. Chem. 393, 413-420.
5. de Veer, S.J., Swedberg, J.E., Parker, E.A., and Harris, J.M. (2012). Non-combinatorial library screening reveals subsite cooperativity and identifies new high-efficiency substrates for kallikreinrelated peptidase 14. Biol. Chem. 393, 331-341.
6. Lose, F., Lawrence, M.G., Srinivasan, S., O'Mara, T., Marquart, L., Chambers, S., Gardiner, R.A., Aitken, J.F., Spurdle, A.B., Batra, J., et al. (2012). Kallikrein 14 is down-regulated by androgen receptor signalling and harbours genetic variation that is associated with prostate tumour aggressiveness. Biol. Chem. 393, 403-412.
7. Mavridis, K. and Scorilas, A. (2010). Prognostic value and biological role of the kallikrein-related peptidases in human malignancies. Future Oncol. 6, 269-285.
8. Oikonomopoulou, K., Diamandis, E.P., and Hollenberg, M.D. (2010). Kallikrein-related peptidases: proteolysis and signaling in cancer, the new frontier. Biol. Chem. 391, 299-310.
9. Pasic, M.D., Olkhov, E., Bapat, B., and Yousef, G.M. (2012). Epigenetic regulation of kallikrein-related peptidases: there is a whole new world out there. Biol. Chem. 393, 319-330.
10. Ramachandran, R., Eissa, A., Mihara, K., Oikonomopoulou, K., Saifeddine, M., Renaux, B., Diamandis, E.P., and Hollenberg, M.D. (2012). Proteinase-activated receptors (PARs): differential signalling by kallikrein-related peptidases KLK8 and KLK14. Biol. Chem. 393, 421-427.
11. Scarisbrick, I.A., Radulovic, M., Burda, J., Larson, N., Blaber, S.I., Giannini, C., Blaber, M., and Vandell, A.G. (2012). Kallikrein 6 is a novel molecular trigger of reactive astrogliosis. Biol. Chem. 393, 355-367.
12. Seiz, L., Dorn, J., Kotzsch, M., Walch, A., Grebenchtchikov, N.I., Gkazepis, A., Schmalfeldt, B., Kiechle, M., Bayani, J., Diamandis, E.P., et al. (2012). Stromal cell-associated expression of kallikrein-related peptidase 6 (KLK6) indicates poor prognosis of ovarian cancer patients. Biol. Chem. 393, 391-401.
13. Swedberg, J.E., de Veer, S.J., and Harris, J.M. (2010). Natural and engineered kallikrein inhibitors: an emerging pharmacopoeia. Biol. Chem. 391, 357-374.
14. White, N.M.A., Youssef, Y.M., Fendler, A., Stephan, C., Jung, K., and Yousef, G.M. (2012). The miRNA-kallikrein axis of interaction: a new dimension in the pathogenesis of prostate cancer. Biol. Chem. 393, 379-389.